Status: Not yet recruiting
Clinical Study on the Efficacy and Safety of Hydromorphone for ICU Analgesia
This study is a prospective, single-center clinical study to evaluate the advantages, extensibility and safety of hydromorphone as an analgesic drug in ICU, and to compare it with remifentanil, a traditional sedative drug. These conclusions can guide us to understand the characteristics of analgesic drugs, carry out appropriate pain management, improve the status of ICU patients, and improve the quality of life of patients.
Participants needed: 300
Trial details
Age: 18-75Biological sex: AllType: ObservationalSponsor: Affiliated Hospital of Nantong UniversityUpdated: Mar 14, 2025Locations: 1
Eligibility criteria
Age ≥18 years and ≤75 years; [+2]
Under 18 years of age, or over 75 years of age; [+18]